Focus: Aria CV is a public biotechnology company focused on pulmonary hypertension device systems, operating from St. Paul, Minnesota since 2010. The company specializes in innovative cardiovascular devices for PAH and acute pulmonary hypertension management.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Stable — net -3 jobs in 30d
5 added, 8 removed. Backfill posture.
Aria CV offers a specialized device-focused opportunity in a growing therapeutic area, but minimal hiring velocity and opaque financials suggest this is a niche-stage company best suited for candidates seeking deep technical ownership over broad career growth.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Aria CV
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Aria CV's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo